This medical condition has either been superseded or has become inactive
| Specific Conditions |
|
| Level of Evidence | Evidence of probable benefit – more research needed (Category 2a) |
|
Intravenous immunoglobulin (IVIg) may be indicated in select cases. Tagami et al (1996) have shown that IVIg is effective in this condition. Other studies have shown IVIg to be as effective as corticosteroids, with fewer side effects. May be indicated where steroids have failed or are contraindicated. Refer to the current product information sheet for further information. The aim should be to use the lowest dose possible that achieves the appropriate clinical outcome for each patient. |
|
| Bibliography |
|---|
| Tagami, T, Tanaka, K, Sugawa, H, et al 1996, ‘High-dose intravenous steroid pulse therapy in thyroid associated ophthalmopathy’, Endocrine Journal, vol. 43, no. 6, pp. 689–99. |